ICU ADVISES MRIYA FARMING PLC ON THE SALE OF UKRAINIAN FARMING ASSETS TO SALIC UK LTD

ICU, an independent asset management, private equity and investment advisory firm, is pleased to announce that it advised Mriya Farming PLC (UK) on restructuring and sale of its farming assets to SALIC UK Ltd (Saudi Agricultural and Livestock Investment Company, United Kingdom).

Both parties have entered into a share purchase agreement for the sale to SALIC of the Mriya group's Ukrainian farming assets, including infrastructure facilities, machinery, and companies owning land lease agreements. The value and terms of the transaction are not disclosed. ICU advised to Mriya in the sale transaction (and to Mriya's creditors in the recent restructuring of Mriya) in collaboration with Rothschild & Co, Finpoint and Hogan Lovells International LLP.

Completion of the transaction is subject to approval from the Antimonopoly Committee of Ukraine (AMCU) and other customary closing conditions. Upon completion of the deal, Mriya will continue its operations in Ukraine alongside SALIC's subsidiary, Continental Farmers Group (CFG).

Commenting on the transaction, Makar Paseniuk, Managing Partner of ICU, said:

“It’s a significant deal for Ukraine. Firstly, it sends a strong signal to the world that foreign creditors rights are recognized and protected in Ukraine. Secondly, the agriculture sector in Ukraine requires investment in resources and expertise and Salic is able to do both. Finally, this deal demonstrates fundamental changes in the investment climate and we expect this paves the way for more such deals.”

ENDS

About ICU

ICU is an independent asset management, private equity and investment advisory firm specialising in the emerging markets of Central and Eastern Europe.

Founded in 2006 by senior investment professionals from ING, ICU is Ukraine's leading asset manager. We currently manage over $500m in assets.

Our veteran investment team has experience in private equity, high yield corporate debt, distressed debt, restructurings and other special situations across a number of emerging markets. Investment decisions are supported by robust macroeconomic and sectoral analyses from our in-house team of research economists.

We aim to provide our clients with superior risk-adjusted returns across a number of asset classes. The firm is expanding its reach into key European markets via a combination of organic growth and acquisition and continues to expand the range its investment offerings.